LA
RMD icon

Legacy Advisors’s ResMed RMD Stock Holding History

Legacy Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,676
Closed -$1.05M – 325
2025
Q1 		$1.05M Sell
4,676
-64
-1% -$14.9K 0.11% 159
2024
Q4 		$1.08M Buy
4,740
+81
+2% +$19.5K 0.11% 150
2024
Q3 		$1.14M Sell
4,659
-470
-9% -$105K 0.12% 135
2024
Q2 		$982K Buy
5,129
+130
+3% +$26.4K 0.12% 132
2024
Q1 		$990K Buy
4,999
+335
+7% +$61.4K 0.13% 135
2023
Q4 		$802K Buy
4,664
+221
+5% +$34K 0.1% 154
2023
Q3 		$657K Buy
4,443
+881
+25% +$159K 0.11% 159
2023
Q2 		$778K Buy
3,562
+171
+5% +$38.1K 0.12% 138
2023
Q1 		$743K Buy
3,391
+264
+8% +$57.3K 0.14% 116
2022
Q4 		$651K Buy
3,127
+981
+46% +$216K 0.12% 124
2022
Q3 		$468K Buy
2,146
+516
+32% +$117K 0.1% 132
2022
Q2 		$342K Buy
1,630
+577
+55% +$123K 0.07% 158
2022
Q1 		$255K Buy
+1,053
New +$255K 0.05% 178

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legacy Advisors's RMD Position: Q2 2025 in Review

Legacy Advisors sold out of ResMed (RMD) in Q2 2025, closing a stake of 4,676 shares — an estimated $1.05M sold.

Legacy Advisors first reported a position in RMD in Q1 2022 and held it in 13 quarters. The position peaked at $1.14M in Q3 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Legacy Advisors reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 4,676 ResMed shares in Q2 2025, an estimated $1.05M.
  • Legacy Advisors first reported a position in ResMed in Q1 2022 and held it in 13 quarters.
  • Legacy Advisors's ResMed position peaked at $1.14M in Q3 2024.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.